معرفی
Dr. Wajih Kidwai is an Associate Professor of Medicine at Yale School of Medicine and serves as Medical Director of Smilow Cancer Hospital in Guilford. He has been affiliated with Yale New Haven Hospital since 2001, leading a high-volume oncology practice along the Connecticut shoreline.
- Academic Track: Yale School of Medicine
- Leadership Role: Medical Director, Smilow Cancer Guilford (2012-present)
Dr. Kidwai specializes in medical oncology/hematology with clinical expertise in breast oncology, Gastrointestinal oncology, and hematologic oncology. His research focuses on:
- Clinical trials for metastatic HER-2-positive breast cancer
- Quality improvement in cancer care through goals-of-care documentation
- Hematopoietic growth factor guidelines
- Survivorship programs and smoking cessation integration
Recent publications highlight his work in multiple myeloma treatment, hematopoietic growth factors, and metastatic cancer care. He actively participates in:
- NCCN Hematopoietic Panel (2018-present)
- Yale IRB Oncology Protocols
- Clinical Research Working Group (CRWG)
Scientific accolades include:
- Trainee Investigator Award (National)
- Department of Medicine Scholarly Activity Award
- ASCO Merit Award
He mentors Yale medical students through clerkship rotations and the Longitudinal Clinical Experience (LCE) program, while collaborating across disciplines with radiation oncology, breast surgery, and palliative care teams.